» Articles » PMID: 34974814

Prostate-specific Membrane Antigen Modulates the Progression of Prostate Cancer by Regulating the Synthesis of Arginine and Proline and the Expression of Androgen Receptors and Fos Proto-oncogenes

Overview
Journal Bioengineered
Date 2022 Jan 3
PMID 34974814
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of prostate-specific membrane antigen (PSMA) is strikingly upregulated during oncogenesis and prostate cancer (PCa) progression, but the functions of this antigen in PCa remain unclear. Here, we constructed PSMA-knockdown LNCaP and 22rv1 cell lines and performed metabonomic and transcriptomic analyses to determine the effects of PSMA on PCa metabolism and transcription. The metabolism of arginine and proline was detected using specific kits. The mRNA and protein expression levels of the identified differentially expressed genes were quantified by RT-qPCR and Western blotting. The proliferation of each cell line was evaluated through CCK-8, EdU and colony formation assays. The migration and invasion abilities of each cell line were detected using wound healing and transwell assays, respectively. PSMA knockdown led to metabolic disorder and abnormal transcription in PCa and resulted in inhibition of the proliferation and metastasis of PCa cells in vitro and in vivo. The depletion of PSMA also promoted the biosynthesis of arginine and proline, inhibited the expression of AR and PSA, and induced the expression of c-Fos and FosB. PSMA plays an important role in the metabolism, proliferation and metastasis of human PCa and may be a promising therapeutic target.

Citing Articles

Lathyrol affects the expression of AR and PSA and inhibits the malignant behavior of RCC cells.

Song S, Tai L, Zhou L, Jiang J, Zhao J Open Med (Wars). 2025; 20(1):20241136.

PMID: 39927164 PMC: 11806241. DOI: 10.1515/med-2024-1136.


The prognostic and neuroendocrine implications of SLC25A29-mediated biomass signature in prostate cancer.

Wu C, Hu S, Dong S, Tzou K, Li C Geroscience. 2025; .

PMID: 39890746 DOI: 10.1007/s11357-025-01538-4.


Prostate-Specific Membrane Antigen Biology and Pathophysiology in Prostate Carcinoma, an Update: Potential Implications for Targeted Imaging and Therapy.

Maes J, Gesquiere S, De Spiegeleer A, Maes A, Van de Wiele C Int J Mol Sci. 2024; 25(17).

PMID: 39273701 PMC: 11396261. DOI: 10.3390/ijms25179755.


From Oncogenesis to Theranostics: The Transformative Role of PSMA in Prostate Cancer.

Hameed M, Gul M, Chaudhry A, Muzaffar H, Sheikh M, Chee W Cancers (Basel). 2024; 16(17).

PMID: 39272896 PMC: 11394180. DOI: 10.3390/cancers16173039.


Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis.

Gao S, Tan H, Li D J Cell Mol Med. 2023; 27(18):2661-2674.

PMID: 37431884 PMC: 10494293. DOI: 10.1111/jcmm.17841.


References
1.
Bullock N, Potts J, Simpkin A, Koupparis A, Harper S, Oxley J . Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion. J Clin Pathol. 2015; 69(2):171-5. PMC: 4752636. DOI: 10.1136/jclinpath-2015-203125. View

2.
Verma I, Sassone-Corsi P . Proto-oncogene fos: complex but versatile regulation. Cell. 1987; 51(4):513-4. DOI: 10.1016/0092-8674(87)90115-2. View

3.
Mahmood T, Yang P . Western blot: technique, theory, and trouble shooting. N Am J Med Sci. 2012; 4(9):429-34. PMC: 3456489. DOI: 10.4103/1947-2714.100998. View

4.
Lee S, Zhang Y, Lee S, Jung C, Li X, Kim H . Targeting prostate cancer with conditionally replicative adenovirus using PSMA enhancer. Mol Ther. 2004; 10(6):1051-8. DOI: 10.1016/j.ymthe.2004.08.028. View

5.
Beketova E, Fang S, Owens J, Liu S, Chen X, Zhang Q . Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer. Cancer Res. 2020; 80(22):4904-4917. PMC: 7669631. DOI: 10.1158/0008-5472.CAN-20-1228. View